PuSH - Publication Server of Helmholtz Zentrum München: Immunization of Patients with Malignant Melanoma with Autologous CD34+ Cell-Derived Dendritic Cells Transduced Ex Vivo with a Recombinant Replication-Deficient Vaccinia Vector Encoding the Human Tyrosinase Gene : A Phase I Trial.

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

di Nicola, M.* ; Carlo-Stella, C.* ; Anichini, A.* ; Mortarini, R.* ; Guidetti, A.* ; Tragni, G.* ; Gallino, F.* ; del Vecchio, M.* ; Ravagnani, F.* ; Morelli, D.* ; Chaplin, P.* ; Arndtz, N.* ; Sutter, G.

Immunization of Patients with Malignant Melanoma with Autologous CD34+ Cell-Derived Dendritic Cells Transduced Ex Vivo with a Recombinant Replication-Deficient Vaccinia Vector Encoding the Human Tyrosinase Gene : A Phase I Trial.

Hum. Gene Ther. 14, 1347-1360 (2003)

DOI

Open Access Green as soon as Postprint is submitted to ZB.

Abstract
Metrics
Extra information

Altmetric

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Scientific Article

Corresponding Author

ISSN (print) / ISBN 1043-0342

e-ISSN 1557-7422

Journal Human Gene Therapy. Clinical Development

Quellenangaben Volume: 14, Pages: 1347-1360

Publisher Mary Ann Liebert

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) Institute of Virology (VIRO)